Bioavailability studies of acetaminophen and nitrofurantoin. 1974

K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner

UI MeSH Term Description Entries
D008297 Male Males
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
November 1974, Journal of pharmaceutical sciences,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
November 1975, American journal of hospital pharmacy,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
January 1978, Antibiotics and chemotherapy,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
August 1979, Archiv der Pharmazie,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
August 1976, Clinical pharmacology and therapeutics,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
October 1983, Journal of pharmacokinetics and biopharmaceutics,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
January 1981, Indian journal of physiology and pharmacology,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
January 1979, Arzneimittel-Forschung,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
April 1987, Indian pediatrics,
K S Albert, and A J Sedman, and P Wilkinson, and R G Stoll, and W J Murray, and J G Wagner
January 1990, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!